Other Species / Isoforms
  TAZ (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K46-ub
KPSSWRKkILPESFF
0 1
TAZ (human) KPSSWRKkILPESFF K46-ub
TAZ (mouse) KPSSWRKKILPESFF K46
TAZ (rat) KPSSWRKKILPESFF K46
S58-p
SFFKEPDsGsHsRQs
0 22
TAZ (human) SFFKEPDsGsHsRQs S58-p
TAZ (mouse) SFFKEPDSGsHsRQs S58
TAZ (rat) SFFKEPDSGSHSRQS S58
S60-p
FKEPDsGsHsRQsst
0 20
TAZ (human) FKEPDsGsHsRQsst S60-p
TAZ (mouse) FKEPDSGsHsRQssT S60-p
TAZ (rat) FKEPDSGSHSRQSST S60
S62-p
EPDsGsHsRQsstDs
0 30
TAZ (human) EPDsGsHsRQsstDs S62-p
TAZ (mouse) EPDSGsHsRQssTDs S62-p
TAZ (rat) EPDSGSHSRQSSTDS S62
S65-p
sGsHsRQsstDssGG
0 49
TAZ (human) sGsHsRQsstDssGG S65-p
TAZ (mouse) SGsHsRQssTDssGG S65-p
TAZ (rat) SGSHSRQSSTDSSGG S65
S66-p
GsHsRQsstDssGGH
1 65
TAZ (human) GsHsRQsstDssGGH S66-p
TAZ (mouse) GsHsRQssTDssGGH S66-p
TAZ (rat) GSHSRQSSTDSSGGH S66
T67-p
sHsRQsstDssGGHP
0 35
TAZ (human) sHsRQsstDssGGHP T67-p
TAZ (mouse) sHsRQssTDssGGHP T67
TAZ (rat) SHSRQSSTDSSGGHP T67
S69-p
sRQsstDssGGHPGP
0 42
TAZ (human) sRQsstDssGGHPGP S69-p
TAZ (mouse) sRQssTDssGGHPGP S69-p
TAZ (rat) SRQSSTDSSGGHPGP S69
S70-p
RQsstDssGGHPGPR
0 32
TAZ (human) RQsstDssGGHPGPR S70-p
TAZ (mouse) RQssTDssGGHPGPR S70-p
TAZ (rat) RQSSTDSSGGHPGPR S70
S87-p
GGAQHVRsHssPAsL
0 7
TAZ (human) GGAQHVRsHssPAsL S87-p
TAZ (mouse) GGAQHVRSHssPAsL S87
TAZ (rat) GGAQHVRSHSSPASL S87
S89-p
AQHVRsHssPAsLQL
Upstream
Downstream
14 96
TAZ (human)
S89-p
TAZ (mouse)
S89-p
TAZ (rat)
S89-p
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • cell growth, inhibited
  • cell motility, inhibited
  • transcription, altered
  • transcription, inhibited
Putative in vivo kinases:
  • LATS1 (human)
  • LATS2 (human)
Regulatory protein:
  • Scribble (human)
Treatment
  • 2-deoxyglucose
  • acadesine
  • metastatic potential
  • miRNA
  • phenformin
TAZ (human) AQHVRsHssPAsLQL S89-p
TAZ (mouse) AQHVRSHssPAsLQL S89-p
TAZ (rat) AQHVRSHSSPASLQL S89
S90-p
QHVRsHssPAsLQLG
Upstream
Downstream
2 20
Effects on Modified Protein
  • activity, inhibited
  • protein degradation
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • cell growth, inhibited
  • cell motility, inhibited
  • transcription, inhibited
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • metastatic potential
  • taxol
TAZ (human) QHVRsHssPAsLQLG S90-p
TAZ (mouse) QHVRSHssPAsLQLG S90-p
TAZ (rat) QHVRSHSSPASLQLG S90
S93-p
RsHssPAsLQLGtGA
0 15
TAZ (human) RsHssPAsLQLGtGA S93-p
TAZ (mouse) RSHssPAsLQLGTGA S93-p
TAZ (rat) RSHSSPASLQLGTGA S93
T98-p
PAsLQLGtGAGAAGs
0 1
TAZ (human) PAsLQLGtGAGAAGs T98-p
TAZ (mouse) PAsLQLGTGAGAAGG T98
TAZ (rat) PASLQLGTGAGAAGG T98
S105-p
tGAGAAGsPAQQHAH
Upstream
Downstream
2 19
Effects on Modified Protein
  • activity, inhibited
  • protein degradation
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • cell growth, inhibited
  • cell motility, inhibited
  • transcription, inhibited
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • nocodazole
  • taxol
TAZ (human) tGAGAAGsPAQQHAH S105-p
TAZ (mouse) TGAGAAGGPAQQHAH G105
TAZ (rat) TGAGAAGGPAQQHAH G105
S117-p
HAHLRQQsYDVTDEL
1 5
TAZ (human) HAHLRQQsYDVTDEL S117-p
TAZ (mouse) HAHLRQQsYDVTDEL S117-p
TAZ (rat) HAHLRQQSYDVTDEL S117
S173-p
MNLHPAVsStPVPQR
0 1
TAZ (human) MNLHPAVsStPVPQR S173-p
TAZ (mouse) VNLHPSITSTSVPQR T173
TAZ (rat) VNLHPTITSTSVPQR T173
T175-p
LHPAVsStPVPQRSM
Upstream
Downstream
1 0
Effects on Modified Protein
  • protein degradation
Treatment
  • taxol
TAZ (human) LHPAVsStPVPQRSM T175-p
TAZ (mouse) LHPSITSTSVPQRSM T175
TAZ (rat) LHPTITSTSVPQRSM T175
S185-p
PQRSMAVsQPNLVMN
0 1
TAZ (human) PQRSMAVsQPNLVMN S185-p
TAZ (mouse) PQRSMAVSQPNLAMN S185
TAZ (rat) PQRSMAVSQPNLAMN S185
T285-p
AVNPPTMtPDMRsIT
Upstream
Downstream
1 0
Effects on Modified Protein
  • protein degradation
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • taxol
TAZ (human) AVNPPTMtPDMRsIT T285-p
TAZ (mouse) PVNTPAMSTDMRSVT S280
TAZ (rat) PVNTPAMNTDMRSVT N280
S290-p
TMtPDMRsITNNsSD
0 1
TAZ (human) TMtPDMRsITNNsSD S290-p
TAZ (mouse) AMSTDMRSVTNSSsD S285
TAZ (rat) AMNTDMRSVTNSSSD S285
S295-p
MRsITNNsSDPFLNG
0 2
TAZ (human) MRsITNNsSDPFLNG S295-p
TAZ (mouse) MRSVTNSSsDPFLNG S290
TAZ (rat) MRSVTNSSSDPFLNG S290
S296
RsITNNsSDPFLNGG
0 1
TAZ (human) RsITNNsSDPFLNGG S296
TAZ (mouse) RSVTNSSsDPFLNGG S291-p
TAZ (rat) RSVTNSSSDPFLNGG S291
S307-p
LNGGPYHsREQstDs
0 3
TAZ (human) LNGGPYHsREQstDs S307-p
TAZ (mouse) LNGGPYHsREQSTDs S302-p
TAZ (rat) LNGGPYHSREQSTDS S302
S311-p
PYHsREQstDsGLGL
Upstream
Downstream
2 9
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Regulatory protein:
  • Scribble (human)
TAZ (human) PYHsREQstDsGLGL S311-p
TAZ (mouse) PYHsREQSTDsGLGL S306
TAZ (rat) PYHSREQSTDSGLGL S306
T312-p
YHsREQstDsGLGLG
0 6
TAZ (human) YHsREQstDsGLGLG T312-p
TAZ (mouse) YHsREQSTDsGLGLG T307
TAZ (rat) YHSREQSTDSGLGLG T307
S314-p
sREQstDsGLGLGCy
1 6
TAZ (human) sREQstDsGLGLGCy S314-p
TAZ (mouse) sREQSTDsGLGLGCy S309-p
TAZ (rat) SREQSTDSGLGLGCY S309
Y321-p
sGLGLGCySVPTtPE
3 0
TAZ (human) sGLGLGCySVPTtPE Y321-p
TAZ (mouse) sGLGLGCySVPTTPE Y316-p
TAZ (rat) SGLGLGCYSVPTTPE Y316
T326-p
GCySVPTtPEDFLSN
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, inhibited
  • protein degradation
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • cell growth, inhibited
  • cell motility, inhibited
  • transcription, inhibited
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • taxol
TAZ (human) GCySVPTtPEDFLSN T326-p
TAZ (mouse) GCySVPTTPEDFLSN T321
TAZ (rat) GCYSVPTTPEDFLSN T321
T346-p
TGENAGQtPMNINPQ
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, inhibited
  • protein degradation
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • cell growth, inhibited
  • cell motility, inhibited
  • transcription, inhibited
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • taxol
TAZ (human) TGENAGQtPMNINPQ T346-p
TAZ (mouse) TGENSGQTPMTVNPQ T341
TAZ (rat) TGENSGQTPMTVNPQ T341
K392-sm
DVESALNksEPFLTW
0 1
TAZ (human) DVESALNksEPFLTW K392-sm
TAZ (mouse) DVESALNKSEPFLTW K387
TAZ (rat) DVESALNKsEPFLTW K387
S393-p
VESALNksEPFLTWL
0 4
TAZ (human) VESALNksEPFLTWL S393-p
TAZ (mouse) VESALNKSEPFLTWL S388
TAZ (rat) VESALNKsEPFLTWL S388-p